Accelrys Pins Success of Upcoming DS 1.5 Release on New Usability Testing Strategy | GenomeWeb

With its Discovery Studio 1.5 modeling platform scheduled to begin shipping just after the new year, Accelrys is putting the finishing touches on a system that CEO Mark Emkjer recently called one of the "most significant product releases in our company's history."

To prepare for the launch, the company carried out several rounds of usability testing to ensure that the new product met user needs — a "relatively new" strategy for Accelrys, according to David Edwards, director of life sciences at the company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.